AI assistant
WEST PHARMACEUTICAL SERVICES INC — Director's Dealing 2014
Dec 1, 2014
30339_dirs_2014-12-01_e1ea44ef-1d3e-4b1f-806f-793977536bcd.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2014-11-26
Reporting Person: LUZZI RICHARD D (Sr. VP, Human Resources)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-11-26 | Common Stock | S | 8000.0000 | $52.1088 | Disposed | 83335.0520 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 960.6360 | Indirect |
| Common Stock | 9236.6504 | Indirect |
Footnotes
F1: The price reported in Column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $52.092 to $52.195, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each seperate price within the range in this footnote.
F2: Reflects additional shares purchased through dividend reinvestments based on most recent plan statement.